Effect of cytomegalovirus infection status on first-year mortality rates among orthotopic liver transplant recipients

Annals of Internal Medicine

Volumn 126, Issue 4, 1997, Pages 275-279

  Falagas, Matthew E ^a,b   Snydman, David R ^a,b   Griffith, John ^a,b   Ruthazer, Robin ^a,b   Werner, Barbara G ^a  

^a Massachusetts State Laboratory   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BACTEREMIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; MYCOSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REOPERATION;

EID: 0031058988     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-126-4-199702150-00003     Document Type: Article

References (19)

1. Wiesner RH, Marin E, Porayko MK, Steers JL, Krom RA, Paya CV. Advances in the diagnosis, treatment, and prevention of cytomegalovirus infections after liver transplantation. Gastroenterol Clin North Am. 1993:22:351-66.
2. Todo S. Fung JJ, Starzl TE, Tzakis A, Doyle H, Abu-Elmagd K, et al. Single-center experience with primary orthotopic liver transplantation with FK 506 immunosuppression. Ann Surg. 1994;220:297-309.
3. Delmonico FL, Jenkins RL, Freeman R, Vacant! J. Bradley J, Dienstag JL, et al. The high-risk liver allograft recipient. Should allocation policy consider outcome? Arch Surg. 1992;127:579-84.
4. Adler M, Gavaler JS, Duquesnoy R, Fung JJ, Svanas G, Starzl TE, et al. Relationship between the diagnosis, preoperative evaluation, and prognosis after orthotopic liver transplantation. Ann Surg. 1988;208:196-202.
5. Motschman TU, Taswell HF, Brecher ME, Rakela J, Grambsch PM, Larson-Keller JJ, et al. Intraoperative blood loss and patient and graft survival in orthotopic liver transplantation: their relationship to clinical and laboratory data. Mayo Clin Proc. 1989;64:346-55.
6. Baliga P, Merion RM, Turcotte JG, Ham JM, Henley KS, Lucey MR. et al. Preoperative risk factor assessment in liver transplantation. Surgery. 1992; 112:704-11.
7. Cuervas-Mons V, Millan I, Gavaler JS, Starzl TE, Van Thiel DH. Prognostic value of preoperatively obtained clinical and laboratory data in predicting survival following orthotopic liver transplantation. Hepatology. 1986;6:922-7.
8. Gonwa TA, Klintmalm GB, Levy M, Jennings LS, Goldstein RM, Husberg BS. Impact of pretransplant renal function on survival after liver transplantation. Transplantation. 1995;59:361-5.
9. Piku! J, Sharpe MD, Lowndes R, Ghent CN. Degree of preoperative malnutrition is predictive of postoperative morbidity and mortality in liver transplant recipients. Transplantation. 1994;57:469-72.
10. Stratta RJ, Shaeffer MS, Markin RS, Wood RP, Langnas AN, Reed EC et al. Cytomegalovirus infection and disease after liver transplantation. An overview. Dig Dis Sci. 1992:37:673-88.
11. Grattan MT, Moreno-Cabral CE. Starnes VA. Oyer PE. Stinson EB. Shumway NE. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA. 1989:261:3561-6.
12. Ettinger N A, Bailey TC, Trulock EP, Storch GA, Anderson D, Raab S, et al. Cytomegalovirus infection and pneumonitis. Impact after isolated lung transplantation. Washington University Lung Transplant Group. Am Rev Respir Dis. 1993:147:1017-23.
13. Snydman DR, Werner BG, Dougherty NN, Griffith J, Rubin RH, Dienstag JL, et al. Cytomegalovirus immune globulin prophylaxis in liver transplantation. A randomized, double-blind, placebo-controlled trial. The Boston Center for Liver Transplantation CMVIG Study Group. Ann Intern Med. 1993; 119:984-91.
14. Falagas ME. Snydman DR, Griffith J, Werner BG. Exposure to cytomegalovirus from the donated organ is a risk factor for bacteremia in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG Study Group. Clin Infect Dis. 1996:23:468-74.
15. SAS/STAT User's Guide. Version 6,4th edition. Cary, NC: SAS Institute. Inc.; 1990.
16. Markus BH, Duquesnoy RJ, Gordon RD, Fung JJ, Vanek M, Klintmalm G, et al. Histocompatibility and liver transplant outcome. Does HLA exert a dualistic effect? Transplantation. 1988;46:372-7.
17. Winston DJ, Wirin D, Shaked A, Busuttil RW. Randomised comparison of gandclovir and high-dose acyclovir for long-term cytomegalovirus prophylaxis in liver-transplant recipients. Lancet. 1995;345:69-74.
18. Patel R, Snydman DR, Rubin RH. Ho M. Pescovitz M. Martin M, et al. Cytomegalovirus prophylaxis in solid organ transplant recipients. Transplantation. 1996:61:1279-89.
19. Collins LA. Samore MH, Robert: MS, Luzzati R, Jenkins RL. Lewis WD, et al. Risk factors for invasive fungal infections complicating orthotopic liver transplantation. J Infect Dis. 1994:170:644-52.